J-Y. Han - Research Institute and Hospital, National Cancer Center

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 109 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 1 Expansion Results of IDE397, a First-in-class, Oral, MAT2A Inhibitor (mat2ai) in MTAP Deleted(del) Non-Small Cell Lung Cancer (NSCLC) and Urothelial Cancer (UC)

B. Herzberg, M. Johnson,C. G. Kim,A. Tolcher,J. Rodon,C. Mantia, J. Liu, A. Tripathi, L. Paz-Ares Rodriguez, T. De la Motte Rouge,C. M. Choi,J. Y. Han, L. Kwei, E. Liu,J. Sachdev, M. O'Quigley, M. White,D. Beaupre,H. R. Kim

EUROPEAN JOURNAL OF CANCER (2024): S176-S177

Cited0Views0Bibtex

Preventing Infusion-Related Reactions with Intravenous Amivantamab: Primary Results from SKIPPirr, a Phase 2 Study

G. Lopes,A. I. Spira,J. -Y. Han,J. -Y. Shih, C. Mascaux, U. Basu Roy,J. Zugazagoitia,Y. J. Kim,C. -H. Chiu, S. -W. Kim,E. Nadal,I. Gil-Bazo, S. Murphy,P. Mahadevia, B. G. Anderson,K. Xia, G. Wang,J. M. Bauml,M. Chioda, J. Simoes, L. Paz-Ares

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S104-S105

Cited0Views0Bibtex

70 (PB058): Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-tyrosine Kinase Inhibitor (TKI), in Patients with 3rd Generation EGFR-TKI Resistance in EGFR Mutated Advanced/metastatic Non-Small Cell Lung Cancer (NSCLC)

S.M. Lim, B.C. Cho,J.Y. Han, S.W. Kim, K.H. Lee,M. Nagasaka, A. Jo,E. Seah, C. Kim,T. Reungwetwattana

European Journal of Cancer（2024）

Cited0Views0Bibtex

A Phase I/II Study of Davutamig (REGN5093), a METxMET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update

M-j. Ahn,B. C. Cho,T. M. Kim,J-y. Han, C. Kim,B. Shim, A. Drilon,G. Blumenschein,L. Villaruz,J. E. Gray,J-l. Pujol,H. Lena,D. Moro-Sibilot, J. Perez, D. A. Modi, J. S. Park, S. Patel, S. Li, E. Kim,H. Magnan

ANNALS OF ONCOLOGY (2024): S1673-S1674

Cited0Views0Bibtex

10P Safety and Tolerability of First-Line (1L) Osimertinib (osi) ± Platinum-Pemetrexed in EGFRm Advanced NSCLC: Data from FLAURA2

C.K. Lee,D. Planchard, Y. Fan,A. Poltoratskiy, T.V. Tran, M.H. Leiva Gálvez, K. Nishino, W. Yao,B. Biswas, T. Takahashi, Y. Nerón, V. Sriuranpong, L. Koubkova,J-Y. Han, A. Figueroa, C. Ruscanu, S. Taggart,D. Kulkarni,M. Albayaty, C. Escriu

ESMO Open（2024）

Cited0Views0Bibtex

1269P Preventing Infusion-Related Reactions with Intravenous Amivantamab: Updated Results from SKIPPirr, a Phase II Study

L.G. Paz-Ares,A.I. Spira,J-Y. Han,J-Y. Shih, C. Mascaux, U. Basu Roy,J. Zugazagoitia, Y.J. Kim,C.H. Chiu,S-W. Kim,E. Nadal,I. Gil Bazo,P. Mahadevia, B. Anderson,K. Xia, G. Wang,J.M. Bauml,M. Chioda, J. Simões,G. Lopes

Annals of Oncology (2024): S812

Cited0Views0Bibtex

721Tip A Phase I/II Study of Davutamig (REGN5093), a MET×MET Bispecific Antibody, in Patients with MET-altered, Advanced Non-Small Cell Lung Cancer (ansclc): Trial in Progress Update

M-J. Ahn,B.C. Cho,T.M. Kim,J-Y. Han, C. Kim,B. Shim, A. Drilon,G. Blumenschein,L. Villaruz,J.E. Gray,J-L. Pujol,H. Lena,D. Moro-Sibilot,J. Perez, D.A. Modi, J.S. Park,S. Patel, S. Li, E. Kim,H. Magnan

Annals of Oncology (2024): S1673-S1674

Cited0Views0Bibtex

Trastuzumab Deruxtecan Monotherapy in Pretreated HER2-overexpressing Nonsquamous Non-Small Cell Lung Cancer: DESTINY-Lung03 Part 1

D. Planchard,H. R. Kim,T. Suksombooncharoen, R. Li,J. Samol,Y. Runglodvatana, K. -Y. Lee,G. -C. Chang,D. Kowalski,J. -Y. Han,S. Saw, Y. Huang,A. Sookprasert, E. Nakajima, J. Alfon, Y. -T. Chang,J. C. -H. Yang

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S46-S47

Cited0Views0Bibtex

P3.12D.02 Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-TKI in EGFR Mutated Advanced/metastatic Non-Small Cell Lung Cancer (NSCLC)

S.M. Lim,B.C. Cho,J.Y. Han,S.W. Kim,K.H. Lee,M. Nagasaka, A. Jo,E. Seah, C. Kim,T. Reungwetwattana

Journal of Thoracic Oncology（2024）

Cited0Views0Bibtex

38P Real-world Treatment Patterns and Effectiveness of Subsequent Treatments Following First-Line (1L) Brigatinib for Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) from ALTA-1L

A. Delmonte,M-J. Ahn, S. Ghosh,M.J. Hochmair,T-Y. Yang,J.C-H. Yang,J-Y. Han, K.H. Holmskov, Y. Wu, Y. Wan, M. Lin, J. Kretz, B. Hupf, A.M. Kurec,E. Churchill,R. Fram, C.J. Cabasag, V. Goriya, Y. Zhao,M.R. García Campelo

ESMO Open (2024): 102617

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn